Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential
Clonal hematopoiesis of indeterminate potential (CHIP) has fascinated the medical community for some time. Discovered about a decade ago, this phenomenon links age-related alterations in hematopoiesis not only to the later development of hematological malignancies but also to an increased risk of ea...
Main Authors: | Anna Maria Cacic, Felicitas Isabel Schulz, Ulrich Germing, Sascha Dietrich, Norbert Gattermann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1303785/full |
Similar Items
-
Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
by: Nagendra Boopathy Senguttuvan, et al.
Published: (2021-07-01) -
Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease
by: Yi-Chun Huang, et al.
Published: (2021-09-01) -
JAK2V617F-positive clonal hematopoiesis of indeterminate potential in pregnant women
by: I. A. Olkhovskiy, et al.
Published: (2019-09-01) -
Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies
by: Luka Komic, et al.
Published: (2023-06-01) -
Clonal hematopoiesis of indeterminate potential: clinical relevance of an incidental finding in liquid profiling
by: Hoermann Gregor
Published: (2022-08-01)